| 查看: 522 | 回复: 1 | ||
[求助]
一段英文摘要，需翻译成德文，
|
|
投了一篇的德国SCI杂志，编辑回信“ Dear ***， The manuscript cannot start the review process until the following corrections are made to meet the journal's requirements (see Instructions for authors, as well): - please add: German summary with title translation and German keywords - "conclusion for practice" (end of paper) of max. 1.000 signs 题目及摘要如下 The efficacy and safety of rosuvastatin on short-term treating the aged coronary heart disease patients with diabetes mellitus 【Abstract】Background To evaluate the efficacy and safety of statins on short-term treating coronary heart disease patients with diabetes mellitus aged 75 years or older and compare its effects with different doses of atorvastatin simultaneously. Methods A randomized single-blind parallel controlled study was conducted in 116 aged coronary heart disease patients with diabetes mellitus．The patients were randomly divided into control group and statin treatment groups; receives conventional treatment，rosuvastatin 10mg/d，atorvastatin 10mg/d or 20mg/d for two weeks．Results Levels of fasting plasma APN(adiponectin), hs-CRP(high-susceptible C reactive protein), TC，TG，LDL-C，HDL-C，ALT(alanine transarninase)，AST(aspartate aminotransferase)，CR(creatinine) and CPK(creatine phosphokinase) were tested before and after the treatment. Moreover，the adverse reactions of patients in statins treatment groups wereobserved．The results show that the LDL-C level decreased significantly in statin treatment groups(P<0.05)．Furthermore, the APN and hs-CRP level changed in rosuvastatin group and 20mg/d atorvastatin group． For four treatment groups，the hepatorenal function and CPK level hadn’t significantly changed．Conclusion It was concluded that rosuvastatin 10mg/d was more effective than atorvastatin 10mg/d and 20mg/d in lipid-lowering and non-lipid-lowering on short term treating the aged coronary heart disease patients with diabetes mellitus based upon the results. However，the safety data was similar outcome between them according to a 2-week follow-up study. 【Key Words】 Rosuvastatin；Atorvastatin；Coronary Disease；Diabetes Mellitus；Treatment Outcome 请高手帮忙！还有：第二句"conclusion for practice" (end of paper) of max. 1.000 signs是什么意思？弄不明白 谢谢！ |
回复此楼» 猜你喜欢
请问有评职称，把科研教学业绩算分排序的高校吗
已经有3人回复
-
孩子确诊有中度注意力缺陷
已经有12人回复
-
2025冷门绝学什么时候出结果
已经有3人回复
-
天津工业大学郑柳春团队欢迎化学化工、高分子化学或有机合成方向的博士生和硕士生加入
已经有4人回复
-
康复大学泰山学者周祺惠团队招收博士研究生
已经有6人回复
-
AI论文写作工具：是科研加速器还是学术作弊器？
已经有3人回复
-
2026博士申请-功能高分子，水凝胶方向
已经有6人回复
-
论文投稿，期刊推荐
已经有4人回复
-
硕士和导师闹得不愉快
已经有13人回复
-
请问2026国家基金面上项目会启动申2停1吗
已经有5人回复
2楼2012-01-11 22:50:13